Moomoo AI 已提取核心信息
Novavax, Inc. has announced a significant workforce reduction as part of its global restructuring and cost reduction plan. On January 30, 2024, the company's Board of Directors approved a 12% reduction in its global workforce, which includes a 9% cut in full-time employees and the remainder affecting contractors and consultants. The company anticipates that the full annual impact of the cost savings will be realized in 2025, with approximately 85% of the savings expected in 2024, excluding one-time charges. Novavax is expected to incur one-time charges of $4 million to $7 million for employee severance and benefit costs, primarily within the first quarter of 2024. This reduction will result in a workforce that is about 30% smaller than it was at the end of the first quarter of 2023. The company has made forward-looking statements regarding the expected timing and impact of the cost savings from the restructuring plan, but also cautions that these statements involve risks and uncertainties that could cause actual results to differ materially from expectations.
Novavax, Inc. has announced a significant workforce reduction as part of its global restructuring and cost reduction plan. On January 30, 2024, the company's Board of Directors approved a 12% reduction in its global workforce, which includes a 9% cut in full-time employees and the remainder affecting contractors and consultants. The company anticipates that the full annual impact of the cost savings will be realized in 2025, with approximately 85% of the savings expected in 2024, excluding one-time charges. Novavax is expected to incur one-time charges of $4 million to $7 million for employee severance and benefit costs, primarily within the first quarter of 2024. This reduction will result in a workforce that is about 30% smaller than it was at the end of the first quarter of 2023. The company has made forward-looking statements regarding the expected timing and impact of the cost savings from the restructuring plan, but also cautions that these statements involve risks and uncertainties that could cause actual results to differ materially from expectations.
Novavax, Inc. 宣布大幅裁员，这是其全球重组和成本削减计划的一部分。2024 年 1 月 30 日，公司董事会批准裁员 12% 的全球员工，其中包括裁员 9% 的全职员工，其余部分影响承包商和顾问。该公司预计，成本节省的全部年度影响将在2025年实现，其中约85％的节省预计将在2024年实现，其中不包括一次性费用。预计Novavax将主要在2024年第一季度内一次性支付400万至700万美元的员工遣散费和福利费用。这种裁员将导致员工人数比2023年第一季度末减少约30％。该公司已就重组计划节省成本的预期时机和影响做出了前瞻性陈述，但也警告说，这些陈述涉及风险和不确定性，可能导致实际业绩与预期存在重大差异。
Novavax, Inc. 宣布大幅裁员，这是其全球重组和成本削减计划的一部分。2024 年 1 月 30 日，公司董事会批准裁员 12% 的全球员工，其中包括裁员 9% 的全职员工，其余部分影响承包商和顾问。该公司预计，成本节省的全部年度影响将在2025年实现，其中约85％的节省预计将在2024年实现，其中不包括一次性费用。预计Novavax将主要在2024年第一季度内一次性支付400万至700万美元的员工遣散费和福利费用。这种裁员将导致员工人数比2023年第一季度末减少约30％。该公司已就重组计划节省成本的预期时机和影响做出了前瞻性陈述，但也警告说，这些陈述涉及风险和不确定性，可能导致实际业绩与预期存在重大差异。
有用
没用